![]() Hilary has both BA and MPhil degrees from the University of Leeds. She took this role with a start-up charity after helping to secure the future of the local respite centre for disabled children as its fundraising trustee. ![]() Between 20 she was chief executive of Autistica, the first UK charity dedicated to raising and investing funds in research into the causes and treatment of autism. Hilary has a long background in research-based sales and marketing activity across a range of sectors. She is a Fellow of the British Pharmacological Society. Jenny graduated with Special Honours in Physiology and Pharmacology from the University of Sheffield and gained her PhD and post-doctoral experience at the University of Manchester. For Maxalt® she was part of the worldwide launch team and helped develop Key Opinions Leaders. Prior to moving into consultancy Jenny was a senior scientist with Merck and acquired an unusually broad insight into drug discovery and development making key contributions to two new products - Maxalt® and Emend®. This included Jenny making presentations to the UK and European Parliaments, helping set up the British Autism Study of Infant Siblings and contributing the WHO's mhGAP Invention Guide. Her role with these influential charities spanned a period of profound global change in recognition of the needs of people with autism. Jenny previously served as as 'Director of Research and Programmes, Europe', 'Strategic Fundraiser' and 'Director of Research' with Autism Speaks and Autistica. Currently Jenny serves as Director of Research with Addenbrooke's Charitable Trust where for example, she has worked with fund raisers to support the Personalised Breast Cancer Progamme (led by Prof Caldas) which was included in the House of Commons Science and Technology Committee's review of genome medicine in the NHS. Jenny has 35 years experience across the pharmaceutical, charitable and academic and sectors, mainly focusing on neuroscience but more recently in broader areas. ![]()
0 Comments
Leave a Reply. |